Wpd Pharmaceuticals Inc (TSE:WBIO) has released an update.
WPD Pharmaceuticals Inc. has filed their annual financial statements for 2023 and is actively working to resolve a suspension from trading on the Canadian Securities Exchange. The company has reduced its stake in its Polish subsidiary to around 6%, losing its controlling interest, and is currently seeking additional funds to support operations for 3 to 6 months. WPD Pharmaceuticals is exploring opportunities for strategic investments and acquisitions in Poland and other markets, although there is no certainty of securing the necessary capital or completing any transactions.
For further insights into TSE:WBIO stock, check out TipRanks’ Stock Analysis page.
